-
May 30: The Week in Cancer News
AI can help doctors determine which breast cancer patients qualify for targeted therapy, and cancer deaths among women have increased with rising temperatures in some countries.
by Thomas Celona
-
Celebrity Cancer Stories Can Lack Important Information
News coverage about public figures facing cancer frequently leaves out key details about the diagnosis and fails to provide background information on cancer.
by Laura Gesualdi Gilmore
-
May 23: The Week in Cancer News
Disasters present a threat to cancer care, and understanding prostate cancer screening recommendations after President Joe Biden’s diagnosis.
by Eric Fitzsimmons
-
AACR Annual Meeting 2025
Immunotherapies, cancer vaccines and more from Cancer Today’s coverage of the AACR Annual Meeting 2025.
-
Redefining Cancer Survivorship
As people with advanced disease live longer, they face physical and mental health side effects. Patient advocates say research and care must focus on their unique needs.
by Thomas Celona
-
May 16: The Week in Cancer News
Study examines benefit of PARP inhibitors before surgery in BRCA-related breast cancer, and exercise improves sexual function after prostate cancer treatment.
by Marci A. Landsmann
-
Family of Henrietta Lacks Works for ‘Health Intelligence’
Alfred Lacks Carter Jr. and other family members honor the legacy of Henrietta Lacks by helping others better understand their health care.
by Kevin McLaughlin
-
May 9: The Week in Cancer News
A single dose of HPV vaccine is highly effective, and not all cancers are increasing in people under 50.
by Kevin McLaughlin
-
May 2: The Week in Cancer News
Immunotherapy may treat some early-stage cancer patients without the need for surgery, and exercise found to counter many side effects of cancer treatment.
by Eric Fitzsimmons
-
Researchers Tackle Immune-related Adverse Effects
Scientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.
by Marci A. Landsmann
Cancer Talk
Can Steroids Impair Immunotherapy for Cancer?
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona